Design of a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2/neu, in patients with surgically resected urothelial cancer at high risk of recurrence Meeting Abstract
| Authors: | Bajorin, D. F.; Sharma, P.; Sims, R. B.; Sandler, A.; Lerner, S. P. |
| Abstract Title: | Design of a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2/neu, in patients with surgically resected urothelial cancer at high risk of recurrence |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009802753 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.TPS4673 |
| Notes: | Meeting Abstract: TPS4673 -- Source: Wos |
